The global landscape of approved antibody therapies

por Lyu, Xiaochen, Zhao, Qichao, Hui, Julia, Wang, Tiffany, Lin, Mengyi, Wang, Keying, Zhang, Jialing, Shentu, Jiaqian, Dalby, Paul A, Zhang, Hongyu, Liu, Bo
Publicado 2022

The benefits, limitations and opportunities of preclinical models for neonatal drug development

por Campion, Sarah, Inselman, Amy, Hayes, Belinda, Casiraghi, Costanza, Joseph, David, Facchinetti, Fabrizio, Salomone, Fabrizio, Schmitt, Georg, Hui, Julia, Davis-Bruno, Karen, Van Malderen, Karen, Morford, LaRonda, De Schaepdrijver, Luc, Wiesner, Lutz, Kourula, Stephanie, Seo, Suna, Laffan, Susan, Urmaliya, Vijay, Chen, Connie
Publicado 2022

Comparison of rat and rabbit embryo–fetal developmental toxicity data for 379 pharmaceuticals: on the nature and severity of developmental effects

por Theunissen, Peter T., Beken, Sonja, Beyer, Bruce K., Breslin, William J., Cappon, Gregg D., Chen, Connie L., Chmielewski, Gary, De Schaepdrijver, Luc, Enright, Brian, Foreman, Jennifer E., Harrouk, Wafa, Hew, Kok-Wah, Hoberman, Alan M., Hui, Julia Y., Knudsen, Thomas B., Laffan, Susan B., Makris, Susan L., Martin, Matt, McNerney, Mary Ellen, Siezen, Christine L., Stanislaus, Dinesh J., Stewart, Jane, Thompson, Kary E., Tornesi, Belen, Van der Laan, Jan Willem, Weinbauer, Gerhard F., Wood, Sandra, Piersma, Aldert H.
Publicado 2016